Immunology of Wound Healing.
Ellis S, Lin EJ, Tartar D. · 2018
Read Immunology of Wound Healing. by Ellis S, Lin EJ, Tartar D. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6244748.txt.
Introduction
Ellis, Lin, and Tartar review the immune side of wound healing. Their review appeared in Current Dermatology Reports. Normal skin healing moves through four phases. Blood clotting comes first, then inflammation, growth, and remodelling. Immune cells, skin cells, and deeper skin cells trade signals at each step. Chronic wounds stall when those signals go wrong.
Neutrophils arrive first at the wound bed. When they die and are cleared by macrophages, the wound shifts toward repair. Blood vessels grow and soft repair tissue forms. Fibre making cells then reshape that tissue into scar. The authors name the shift from inflammation to growth as the key turning point. If inflammation runs unchecked, scars form badly or wounds stay open. The review sums up what helps or blocks that shift.
Catalog record
| CREATOR | Ellis S, Lin EJ, Tartar D. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Immunology of Wound Healing By Samantha Ellis, Elaine J. Lin, Danielle Tartar Published in: Current Dermatology Reports DOI: 10.1007/s13671-018-0234-9 ABSTRACT Purpose of Review Chronic wounds are a tremendous burden on the healthcare system and lead to significant patient morbidity and mortality. Normal cutaneous wound healing occurs through an intricate and delicate interplay between the immune system, keratinocytes, and dermal cells. Each cell type contributes signals that drive the normal phases of wound healing: hemostasis, inflammation, proliferation, and remodeling. This paper reviews how various immunological cell types and signaling molecules influence the way wounds develop, persist, and heal. Recent Findings Concurrent with the achievement of hemostasis, neutrophils are the first cells to migrate to the wound bed, brought in by pro-inflammatory signals including IL-8. Their apoptosis and engulfment by macrophages (efferocytosis) provides a key signal to the local immune milieu, including macrophages, to transition to an anti-inflammatory, pro-repair state, where angiogenesis occurs and granulation tissue is laid down. Myofibroblasts, activated through contractile forces and signaling molecules, then drive remodeling, where granulation tissue becomes scar. Unchecked inflammation at this stage can result in abnormal scar formation. Summary Although the derangement of immune signals at any stage can result in impaired wound healing, recent research has shown that the key transition point lies between the inflammatory and the proliferative phases. This review summarizes the events that facilitate this transition and discusses how this process can be disrupted, leading to chronic, non-healing wounds. INTRODUCTION In the USA, chronic wounds afflict approximately 6.5 million individuals, leading the healthcare system to spend over 25 billion dollars, annually, on their treatment [1]. Non-healing wounds are more than just a cost burden, as they have been shown to cause loss of mobility and ability to perform daily tasks, loss of participation in the workforce, and poor quality of life [2, 3]. The effect of non-healing wounds on mortality has even been demonstrated to be comparable to cancer [4]. As the population continues to age, and rates of obesity, diabetes, and cardiovascular disease rise, the number of chronic wounds worldwide is expected to rise as well [5•]. Given the tremendous strain that chronic wounds place on the healthcare system, considerable efforts are underway to investigate the basic science of wound healing and to understand the conditions that lead to chronic wounds. In particular, the immune system has been found to play a substantial role due to its impact on several repair mechanisms [6, 7]. Though the process of wound healing is markedly complex and dependent on the delicate interplay of numerous factors, normal wound healing can generally be broken down into four over-lapping but distinct steps (Fig. 1). These steps include hemostasis (minutes to hours after injury), inflammation (days 1–3), proliferation and repair (days 4–21), and lastly, wound remodeling (days 21–365) [8, 9]. Dysregulation of any of these events can result in delayed wound healing and the potential to form chronic ulcers and/or excessive scarring [10••]. This review summarizes the events taking place in each stage of wound healing, with a focus on immune pathways and how they are disturbed in chronic wounds. New research has illustrated that chronic wounds fail to shift from the inflammatory to the proliferative phase of wound healing, so much of this review will focus on the events that drive this transition.Fig. 1Legend: traditional model of wound healing. Wound healing normally progresses through the hemostasis/inflammatory phase, the proliferative phase, and the remodeling phase. Hemostasis is achieved with production of a fibrin clot. Danger signals are released from platelets and damaged cells, which leads to infiltration and activation of pro-inflammatory cells such as neutrophils and inflammatory-type macrophages. There is an important transition from the inflammatory to the proliferative phase (days 2–5). In chronic wounds, this transition often fails to occur. In the proliferative phase, extracellular matrix (ECM) is laid down to form granulation tissue, and angiogenesis and re-epithelialization occur. Over the next year, the granulation tissue is remodeled into a scar FOUR STAGES OF WOUND HEALING Hemostasis The initial events following injury are designed to achieve hemostasis within the first minutes to hours of injury based on a series of serine protease events designed to prevent blood loss [11]. In this cascade, a series of biologically inert zymogens (enzyme precursors) are activated into fully functional, catalytically active, serine proteases that result in the platelet activation and formation of a fibrin clot. Platelet activation not only results in hemostasis, but also in the release of growth factors such as platelet-derived growth factor (PDGF) as well as immune mediators that are responsible for activation of the immune system and transition to the inflammatory phase of wound healing. The hemostasis phase begins when tissue damage allows blood to leak into the exposed wound site, triggering the extrinsic clotting cascade and releasing mediators that cause localized vasoconstriction, such as serotonin [9]. Platelets subsequently aggregate and activate on subendothelial collagen, leading to formation of a hemostatic plug through their release of cytokines and growth factors [12]. Not only does this mitigate hemorrhage, but also serves as a preliminary matrix for cell migration by releasing scaffold proteins such as fibronectin, vitronectin, and thrombospondins, allowing for the migration of keratinocytes, immune cells, and fibroblasts [9, 13]. Platelet degranulation also leads to the release of inflammatory mediators such as interleukin (IL)-8, or CXCL8 (a potent neutrophil chemoattractant), in addition to IL-1α, IL-1β, IL-6, and tumor necrosis factor (TNF)-α, and activates the complement cascade [9, 14]. After hemostasis is achieved, histamine released by the activated complement cascade causes capillary dilation and leakage, accelerating migration of inflammatory cells into the wound bed and full transition to the inflammatory phase of wound healing [15]. Inflammation The inflammatory phase overlaps considerably with initial hemostasis, occurring during the first 72 h after tissue injury [16]. This phase is principally represented by a complex series of molecular signals that ultimately facilitates neutrophil and monocyte infiltration of the wound bed in order to prevent unnecessary tissue damage and eliminate pathogenic organisms and foreign debris [6, 16]. Inflammatory cell recruitment into the wound site occurs secondary to local stimuli. In an acute wound, injured host cells die and release cellular contents that serve as danger signals (e.g., uric acid, DNA, RNA, extracellular matrix components). These products are collectively referred to as damage-associated molecular patterns (DAMPs) [17, 18]. When a wound is contaminated by a pathogen, pathogen-associated molecular patterns (PAMPs) are also released into the wound milieu [19]. Pattern recognition receptors (e.g., toll-like receptors) on local, tissue-resident cells recognize these danger signals, which leads to local cell activation. Subsequently, these cells express numerous genes that code for important chemical mediators that will propagate the inflammatory response [20, 21]. Neutrophil Activation and Amplification Neutrophils represent the most abundant inflammatory cells to infiltrate a new wound and function mainly to remove debris and prevent infection [22, 23]. Their influx is mediated by a number of chemical signals, including IL-8, or CXCL8, as mentioned above, and neutrophils have over 30 different receptors that mitigate their migration and activation response [24]. It is clear that neutrophils do function in debris removal early in wound healing, but their persistence, as will be discussed in detail below, has been associated with delayed wound healing and chronic wounds. Moreover,